202 related articles for article (PubMed ID: 31127617)
21. Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships.
McManaway ME; Marti GE; Tosato G; Liu AK; al-Nasser AA; Kiwanuka J; Magrath IT
Pathobiology; 1993; 61(3-4):164-72. PubMed ID: 8216838
[TBL] [Abstract][Full Text] [Related]
22. Role and mechanism of PTEN in Burkitt's lymphoma.
Li C; Xu Y; Xin P; Zheng Y; Zhu X
Oncol Rep; 2020 Feb; 43(2):481-490. PubMed ID: 31922234
[TBL] [Abstract][Full Text] [Related]
23. [Effect of bortezomib on lymphoma cell line CA46 and its relative mechanisms].
Huang HB; Zhan R; Wu SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):919-22. PubMed ID: 20723300
[TBL] [Abstract][Full Text] [Related]
24. Effect of citral on the cytotoxicity of doxorubicin in human B-lymphoma cells.
Dangkong D; Limpanasithikul W
Pharm Biol; 2015 Feb; 53(2):262-8. PubMed ID: 25243873
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.
Suk FM; Lin SY; Lin RJ; Hsine YH; Liao YJ; Fang SU; Liang YC
Oncotarget; 2015 Sep; 6(28):25988-6001. PubMed ID: 26317903
[TBL] [Abstract][Full Text] [Related]
26. G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin.
Klucar J; Al-Rubeai M
FEBS Lett; 1997 Jan; 400(1):127-30. PubMed ID: 9000527
[TBL] [Abstract][Full Text] [Related]
27. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
Taylor ST; Hickman JA; Dive C
J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
[TBL] [Abstract][Full Text] [Related]
29. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
30. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.
Richter-Larrea JA; Robles EF; Fresquet V; Beltran E; Rullan AJ; Agirre X; Calasanz MJ; Panizo C; Richter JA; Hernandez JM; Roman-Gomez J; Prosper F; Martinez-Climent JA
Blood; 2010 Oct; 116(14):2531-42. PubMed ID: 20570860
[TBL] [Abstract][Full Text] [Related]
31. Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.
Hussain AR; Ahmed M; Al-Jomah NA; Khan AS; Manogaran P; Sultana M; Abubaker J; Platanias LC; Al-Kuraya KS; Uddin S
Mol Cancer Ther; 2008 Oct; 7(10):3318-29. PubMed ID: 18852135
[TBL] [Abstract][Full Text] [Related]
32. Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells.
Wang W; Luo J; Xiang F; Liu X; Jiang M; Liao L; Hu J
PLoS One; 2014; 9(10):e110101. PubMed ID: 25290311
[TBL] [Abstract][Full Text] [Related]
33. [Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells].
Yu Y; Xie M; He YL; Xu WQ; Zhu S; Cao LZ
Ai Zheng; 2008 Sep; 27(9):929-33. PubMed ID: 18799030
[TBL] [Abstract][Full Text] [Related]
34. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.
Ambroise G; Portier A; Roders N; Arnoult D; Vazquez A
Oncotarget; 2015 Nov; 6(35):38181-94. PubMed ID: 26431330
[TBL] [Abstract][Full Text] [Related]
35. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA.
Otake Y; Soundararajan S; Sengupta TK; Kio EA; Smith JC; Pineda-Roman M; Stuart RK; Spicer EK; Fernandes DJ
Blood; 2007 Apr; 109(7):3069-75. PubMed ID: 17179226
[TBL] [Abstract][Full Text] [Related]
37. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
38. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model.
Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J
Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852
[TBL] [Abstract][Full Text] [Related]
39. Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
Jazirehi AR; Vega MI; Bonavida B
Cancer Res; 2007 Feb; 67(3):1270-81. PubMed ID: 17283164
[TBL] [Abstract][Full Text] [Related]
40. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
